{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-26-211980","form_type":"8-K","ticker":"OM","cik":"0001484612","company_name":"Outset Medical, Inc.","filed_at":"2026-05-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.348404+00:00","generated_at":"2026-05-14T21:35:47.378797+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Outset Medical Q1 revenue down 6% to $27.9M; gross margin expands to 43.4%","bullets":["Revenue $27.9M (-6% YoY); recurring revenue $22.5M roughly flat.","Gross margin 43.4% (up from 37.2% YoY); product gross margin record 52.4%, service margin record 25.5%.","Net loss narrowed to $19.0M from $25.8M; cash $161M at quarter end.","Reiterated FY 2026 revenue guidance $125-130M (5-9% growth) and non-GAAP gross margin low-to-mid 40%."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-211980","json":"https://secwatch.observer/filing/0001193125-26-211980.json","markdown":"https://secwatch.observer/filing/0001193125-26-211980.md","text":"https://secwatch.observer/filing/0001193125-26-211980.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1484612/000119312526211980/0001193125-26-211980-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1484612/000119312526211980/om-20260507.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-14T21:35:47.378797+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"89419a557e2f516ddec14f3e51ce4dd45372dd13","claim":"Outset Medical, Inc. reported the first quarter ended March 31, 2026 results: revenue $27.9 million, net income Net loss was $19.0 million. Guidance reaffirmed.","evidence_excerpt":"Net revenue totaled $27.9 million, a decrease of 6% compared to $29.8 million in the first quarter of 2025.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1484612/000119312526211980/0001193125-26-211980-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter ended March 31, 2026"},{"label":"Revenue","value":"$27.9 million"},{"label":"Net income","value":"Net loss was $19.0 million"},{"label":"Guidance","value":"reaffirmed"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}